EXPERIENCE IN REPEAT MITRAL VALVE REPLACEMENT USING DOMESTIC BIOPROSTHESES IN A PATIENT WITH MITRAL VALVE DEFECT. TREATMENT STRATEGY ANALYSIS: A CLINICAL CASE

Highlights

Presented clinical case describes repeat mitral valve replacement using domestic bioprostheses in a patient with mitral valve defect who had primary mitral regurgitation and subsequently developed bioprosthetic valve dysfunction.

Abstract

Presented clinical case describes a successful repeat mitral valve replacement using domestic bioprostheses in the treatment of recurrent mitral valve regurgitation in a young patient, discusses the advantages and limitations of using biological prostheses and approaches to repeat replacement, and analyzes the adherence to therapy as one of the factors limiting the effectiveness of treatment of patients with bioprosthetic heart valves.

1. A.N. Stasev, Yu.N. Odarenko, S.G. Kokorin, N.V. Rutkovskaya, Yu.V. Levadin,L.S. Barbarash. Multiple use of bioprosthesis in surgery of recurrent mitral disorder: clinical case. Complex Issues of Cardiovascular Diseases. 2018; 7 (4S): 118-122. DOI: 10.17802/2306-1278-2018-7-4S-118-122

2. Barbarash L.S., Rogulina N.V., Rutkovskaya N.V., Odarenko Yu.N., Kokorin S.G. Experience of application of epoxy-treated biological prostheses for mitral valvular disease in patients under 65 years. Russian Journal of Thoracic and Cardiovascular Surgery. 2019; 61 (2): 114–22 (in Russ.). DOI: 10.24022/ 0236-2791-2019-61-2-114-122

3. Barbarash OL, Lyapina IN. Current trends in organizing the care for patients with acquired heart valve disease. Russian Cardiology Bulletin. 2024;19(4):5 12.(In Russ.) https://doi.org/10.17116/Cardiobulletin2024190415

4. Santangelo G, Bursi F, Faggiano A, Moscardelli S, Simeoli PS, Guazzi M, Lorusso R, Carugo S, Faggiano P. The Global Burden of Valvular Heart Disease: From Clinical Epidemiology to Management. Journal of Clinical Medicine. 2023;12(6):2178. https://doi.org/10.3390/jcm12062178

5. Prognosis after surgical replacement with a bioprosthetic aortic valve in patients with severe symptomatic aortic stenosis: systematic review of observational studies. / Foroutan F., Guyatt G.H., O’Brien K., et al. // BMJ. – 2016. – Т. 354. – С. i5065.

6. Odarenko Y.N., Rutkovskaya N.V., Rogulina N.V., Stasev A.N., Kokorin S.G., Kagan E.S., Barbarash L.S. Analysis of 23-year experience epoxy treated xenoaortic bioprosthesisin surgery mitral heart disease. research factors of recipients by positions of influence on the development of calcium degeneration. Complex Issues of Cardiovascular Diseases. 2015;(4):17-25. (In Russ.) https://doi.org/10.17802/2306-1278-2015-4-17-25

7. Lyapina I.N., Dren E.V., Kuzmina O.K., Osintsev E.S., Stasev A.N., Evtushenko A.V., Barbarash O.L. Ten-year dynamics of the phenotype of patients undergoing surgical correction of valvular heart diseases: results of a single-center registry. Russian Journal of Thoracic and Cardiovascular Surgery. 2024; 66 (3): 302–310 (in Russ.). DOI: 10.24022/0236-2791-2024-66-3-302-310

8. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Russian Journal of Cardiology. 2022;27(7):5160. (In Russ.) https://doi.org/10.15829/1560-4071-2022-5160

9. Otto C.M., Nishimura R.A., Bonow R.O., Carabello B.A., Erwin J.P., Gentile F., et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021; 143: e35-71.

10. Kudryavtseva Yu.A., Ovcharenko E.A., Klyshnikov K.Yu., Antonova L.V., Senokosova E.A., Ponasenko A.V., Barbarash O.L., Barbarash L.S. Biological prostheses for cardiovascular surgery – a half-century history and development prospects. Complex Issues of Cardiovascular Diseases. 2024;13(1):196-210. (In Russ.) https://doi.org/10.17802/2306-1278-2024-13-1-196-210

11. Tam H, Zhang W, Infante D, Parchment N, Sacks M, Vyavahare N. Fixation of Bovine Pericardium-Based Tissue Biomaterial with Irreversible Chemistry Improves Biochemical and Biomechanical Properties. J Cardiovasc Transl Res. 2017 Apr;10(2):194-205. doi: 10.1007/s12265-017-9733-5. Epub 2017 Feb 17. PMID: 28213846; PMCID: PMC5903689.

12. van der Zande JA, Ramlakhan KP, Sliwa K, Gnanaraj JP, Al Farhan H, Malhamé I, Otto CM, Vasallo Peraza R, Marelli A, Maggioni AP, Cornette JMJ, Johnson MR, Roos-Hesselink JW, Hall R; ROPAC investigators. Pregnancy with a prosthetic heart valve, thrombosis, and bleeding: the ESC EORP Registry of Pregnancy and Cardiac disease III. Eur Heart J. 2025 Apr 16:ehaf265. doi: 10.1093/eurheartj/ehaf265.

13. Sylvester CB, Ryan CT, Frankel WC, Asokan S, Zea-Vera R, Zhang Q, Wall MJ Jr, Coselli JS, Rosengart TK, Chatterjee S, Ghanta RK. Readmission After Bioprosthetic vs Mechanical Mitral Valve Replacement in the United States. Ann Thorac Surg. 2024 Jan;117(1):113-118. doi: 10.1016/j.athoracsur.2022.05.064.

14. Joshi I, Buber J. Pregnancy with prosthetic heart valves: navigating risks, anticoagulation, and valve function in a growing population. Future Cardiol. 2025 Dec;21(12):1091-1096. doi: 10.1080/14796678.2025.2548152.

15. Leviner, D.B.; Abraham, D.; Ronai, T.; Sharoni, E. Mechanical Valves: Past, Present, and Future-A Review. J. Clin. Med. 2024, 13, 3768. https://doi.org/10.3390/jcm13133768

16. Nishida T., Sonoda H., Oishi Y., Tanoue Y., Nakashima A., Shiokawa Y., Tominaga R. Mechanical prosthesis is reasonable for mitral valve replacement in patients approximately 65 years of age. Ann. Thorac. Surg. 2013;96:1614–1620. doi: 10.1016/j.athoracsur.2013.05.014.

17. Velho TR, Pereira RM, Fernandes F, Guerra NC, Ferreira R, Nobre Â. Bioprosthetic Aortic Valve Degeneration: a Review from a Basic Science Perspective. Braz J Cardiovasc Surg. 2022 May 2;37(2):239-250. doi: 10.21470/1678-9741-2020-0635. PMID: 34673516; PMCID: PMC9054148.

18. Caus T, Chabry Y, Nader J, Fusellier JF, De Brux JL and for the EpiCard investigators (2023) Trends in SAVR with biological vs. mechanical valves in middle-aged patients: results from a French large multi-centric survey. Front. Cardiovasc. Med. 10:1205770. doi: 10.3389/fcvm.2023.1205770

19. Kozlov B.N., Petlin K.A., Pryakhin A.S., Seredkina E.B., Panfilov D.S., Shipulin V.M. Immediate and long-term results of application of UniLine bioprostheses in the aortic position. Clinical and experimental surgery. Petrovsky journal. 2017; 4(18): 37-42 (in Russian).

20. Ovcharenko E.A., Onishchenko P.S., Klyshnikov K.Yu. Optimization of the biological valve appliance prosthetic heart valve. Complex Issues of Cardiovascular Diseases. 2022;11(2): 39-48. DOI: 10.17802/2306-1278-2022-11-2-39-48

21. Pepera, G., Tribali, M. S., Batalik, L., Petrov, I., & Papathanasiou, J. (2022). Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review. Reviews in cardiovascular medicine, 23(1), 28. https://doi.org/10.31083/j.rcm2301028

22. Kulkarni P, Mahadevappa M. The COVID-19 Pandemic Surge and Impact on Rheumatic Valvular Heart Disease Patient Care. J Saudi Heart Assoc. 2021 Nov 3;33(4):261-266. doi: 10.37616/2212-5043.1271. PMID: 35284227; PMCID: PMC8862731.

23. Imran Hamid, U., Digney, R., Soo, L., Leung, S., & Graham, A. N. (2015). Incidence and outcome of re-entry injury in redo cardiac surgery: benefits of preoperative planning. European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery, 47(5), 819–823. https://doi.org/10.1093/ejcts/ezu261

24. Reply to Chen et al. Improvements in Outcomes and Expanding Indications for the Commando Procedure. Comment on “Giambuzzi et al. Surgical Aortic Mitral Curtain Replacement: Systematic Review and Metanalysis of Early and Long-Term Results. J. Clin. Med. 2021, 10, 3163” / I. Giambuzzi, G. Bonalumi, M. Di Mauro [et al.] // Journal of Clinical Medicine. – 2022. – Vol. 11, No. 6. – P. 1601. – DOI 10.3390/jcm11061601. – EDN ZMTXUU.

25. Onorati F., Perrotti A., Reichart D., Mariscalco G., Della Ratta E., Santarpino G. et al. Surgical factors and complications affecting hospital outcome in redo mitral surgery: insights from a multicentre experience.Eur J Cardiothorac Surg. 2016 May;49(5):e127-33. doi: 10.1093/ejcts/ezw048

26. Leontyev S., Leonteva N.V., Dmitrieva Ya., Davierwala P., Borger M.A. EARLY AND LATE OUTCOME AFTER REPAID AORTIC VALVE SURGERY - THE SINGEL CENTRE EXPERIANCE OF HEART CENTER LEIPZIG (GERMANY). Creative surgery and oncology. 2017;7(3):4-12. (In Russ.) https://doi.org/10.24060/2076-3093-2017-7-3-4-12

27. Jamieson W.R., Burr L.H., Miyagishima R.T., Janusz M.T., Fradet G.J., Lichtenstein S.V., Ling H. Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment. Circulation. 2003 Sep 9;108(90101):98II--102. 10.1161/01.cir.0000089184.46999.f4

28. Thyregod HGH, Jørgensen TH, Ihlemann N, Steinbrüchel DA, Nissen H, Kjeldsen BJ, Petursson P, De Backer O, Olsen PS, Søndergaard L. Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial. Eur Heart J. 2024 Apr 1;45(13):1116-1124. doi: 10.1093/eurheartj/ehae043. PMID: 38321820; PMCID: PMC10984572.

29. Ganyukov V.I., Tarasov R.S., Ganyukov I.V. Transseptal transcatheter mitral valve replacement. Russian Journal of Cardiology. 2020;25(8):3842. (In Russ.) https://doi.org/10.15829/1560-4071-2020-3842

30. Yoon SH, Whisenant BK, Bleiziffer S, Delgado V, Dhoble A, Schofer N, Eschenbach L, Bansal E, Murdoch DJ, Ancona M, Schmidt T, Yzeiraj E, Vincent F, Niikura H, Kim WK, Asami M, Unbehaun A, Hirji S, Fujita B, Silaschi M, Tang GHL, Kuwata S, Wong SC, Frangieh AH, Barker CM, Davies JE, Lauten A, Deuschl F, Nombela-Franco L, Rampat R, Nicz PFG, Masson JB, Wijeysundera HC, Sievert H, Blackman DJ, Gutierrez-Ibanes E, Sugiyama D, Chakravarty T, Hildick-Smith D, de Brito FS Jr, Jensen C, Jung C, Smalling RW, Arnold M, Redwood S, Kasel AM, Maisano F, Treede H, Ensminger SM, Kar S, Kaneko T, Pilgrim T, Sorajja P, Van Belle E, Prendergast BD, Bapat V, Modine T, Schofer J, Frerker C, Kempfert J, Attizzani GF, Latib A, Schaefer U, Webb JG, Bax JJ, Makkar RR. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J. 2019 Feb 1;40(5):441-451. doi: 10.1093/eurheartj/ehy590. PMID: 30357365.

31. Ovcharenko E.A., Klyshnikov K.U., Shilov A.A., Scheglova N.A., Glushkova T.V., Nushtaev D.V., Barbarash L.S. Numerical and experimental justification of transcatheter aortic valve prosthesis design. Russian Journal of Transplantology and Artificial Organs. 2021;23(2):95-103. https://doi.org/10.15825/1995-1191-2021-2-95-103

32. Kuzmina O.K., Stasev A.N., Tsenter I.M., Evtushenko A.V., Barbarash O.L., Barbarash L.S. Changes in the portrait of patients with acquired mitral and aortic valve disease before implantation of bioprosthetic heart valves. Complex Issues of Cardiovascular Diseases. 2024;13(4):6-12. (In Russ.) https://doi.org/10.17802/2306-1278-2024-13-4-6-12